JPH09510975A - アレルギー治療用合成ペプチドベース免疫原 - Google Patents

アレルギー治療用合成ペプチドベース免疫原

Info

Publication number
JPH09510975A
JPH09510975A JP7525239A JP52523995A JPH09510975A JP H09510975 A JPH09510975 A JP H09510975A JP 7525239 A JP7525239 A JP 7525239A JP 52523995 A JP52523995 A JP 52523995A JP H09510975 A JPH09510975 A JP H09510975A
Authority
JP
Japan
Prior art keywords
peptide
immunogen
effective amount
vaccine composition
ige
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7525239A
Other languages
English (en)
Japanese (ja)
Inventor
ワン，チャン・イ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United Biomedical Inc
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of JPH09510975A publication Critical patent/JPH09510975A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP7525239A 1994-03-28 1995-03-24 アレルギー治療用合成ペプチドベース免疫原 Pending JPH09510975A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21846194A 1994-03-28 1994-03-28
US08/218,461 1994-03-28
US32891294A 1994-10-25 1994-10-25
US08/328,912 1994-10-25
PCT/US1995/003741 WO1995026365A1 (fr) 1994-03-28 1995-03-24 Immunogenes a base de peptide synthetique pour le traitement de l'allergie

Publications (1)

Publication Number Publication Date
JPH09510975A true JPH09510975A (ja) 1997-11-04

Family

ID=26912926

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7525239A Pending JPH09510975A (ja) 1994-03-28 1995-03-24 アレルギー治療用合成ペプチドベース免疫原

Country Status (6)

Country Link
EP (1) EP0811016A1 (fr)
JP (1) JPH09510975A (fr)
CN (1) CN1146772A (fr)
AU (1) AU2195395A (fr)
CA (1) CA2186595A1 (fr)
WO (1) WO1995026365A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843462A (en) * 1995-11-30 1998-12-01 Regents Of The University Of Minnesota Diphtheria toxin epitopes
CA2245497C (fr) 1996-03-01 2009-02-24 Novartis Ag Immunogenes peptidiques utilises comme vaccins et agents therapeutiques contre les allergies
GB9611673D0 (en) * 1996-06-05 1996-08-07 Peptide Therapeutics Ltd Meningococcal vaccine
EP1037663A2 (fr) 1997-12-16 2000-09-27 Regents Of The University Of Minnesota Procedes permettant de traiter des reponses immunitaires indesirables
TWI227241B (en) 1998-06-20 2005-02-01 United Biomedical Inc IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
US6090388A (en) * 1998-06-20 2000-07-18 United Biomedical Inc. Peptide composition for prevention and treatment of HIV infection and immune disorders
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
HUP0200958A3 (en) 1999-04-23 2004-11-29 Pharmexa As Method for down-regulating il5 activity
GB9913327D0 (en) * 1999-06-08 1999-08-11 Smithkline Beecham Biolog Vaccine
US6846486B1 (en) 2000-02-24 2005-01-25 Advanced Biotherapy Concepts, Inc. Method of treating allergy by administering an anti-histamine antibody
CA2403739A1 (fr) * 2000-03-15 2001-09-20 Heska Corporation Modele tridimensionnel d'un complexe entre une chaine alpha du recepteur fc-epsilon et une region fc d'un anticorps ige et leurs utilisations
AU7658101A (en) * 2000-07-28 2002-02-13 Cytos Biotechnology Ag Compositions for inducing self-specific anti-ige antibodies and uses thereof
IL154219A0 (en) * 2000-09-06 2003-07-31 Pharmexa As Method for down-regulating ige
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
JP2003047482A (ja) 2001-05-22 2003-02-18 Pfizer Prod Inc 非アナフィラキシー誘発性ＩｇＥワクチン
WO2003015716A2 (fr) 2001-08-13 2003-02-27 Ige Therapeutics, Inc. Vaccins d'immunoglobuline e et leurs procedes d'utilisation
IL158287A0 (en) * 2003-10-07 2004-05-12 Yeda Res & Dev Antibodies to nik, their preparation and use
WO2009023816A1 (fr) * 2007-08-15 2009-02-19 Emory University Procédés de préparation d'anticorps monoclonaux utilisant la technologie du transfert adoptif d'épitope de peptide de fusion (f-peat)
CA2717930A1 (fr) * 2008-03-13 2009-09-17 Yossef Kliger Nouveaux peptides derives de gp96
WO2013083254A1 (fr) 2011-12-09 2013-06-13 Bavarian Nordic A/S Vecteur de poxvirus pour l'expression d'antigènes bactériens liés au fragment c de la toxine tétanique
US9187553B2 (en) * 2012-01-25 2015-11-17 Swey-Shen Chen Displaying native human IgE neutralizing FcepsilonRIa-contacting IgE B-cell epitopes by constraining super beta(b)-strands and cystine knots on thermostable protein scaffold
EP2862873B1 (fr) * 2012-06-18 2020-04-29 Nippon Zenyaku Kogyo Co., Ltd. VACCIN À BASE DE PEPTIDE D'IMMUNOGLOBULINE E (IgE)
EP2790442A1 (fr) 2013-04-09 2014-10-15 Alcatel Lucent Système de commande, appareil, procédés et support de stockage lisible par ordinateur stockant des instructions pour un n'ud de réseau et/ou un contrôleur de réseau
CN112237638B (zh) * 2020-10-28 2022-11-29 西安华牧生物科技有限责任公司 降低放射性核素肾浓聚的组合探针及其制备方法
CN114949176A (zh) * 2022-04-11 2022-08-30 中国科学院海洋研究所 一种迟缓爱德华氏菌TraT蛋白的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
US5552537A (en) * 1993-03-24 1996-09-03 The Regents Of The University Of California IgE isoforms and methods of use
WO1994025060A1 (fr) * 1993-04-27 1994-11-10 Ladd Anna E Peptides immunogenes de la lhrh et stimulators d'immunite universelle de synthese pour vaccins
GB9320897D0 (en) * 1993-10-11 1993-12-01 Peptide Therapeutics Ltd Compounds useful in anti-allergy treatment
GB9417086D0 (en) * 1994-08-24 1994-10-12 Peptide Therapeutrics Limited Screen for potential therapeutic compounds

Also Published As

Publication number Publication date
AU2195395A (en) 1995-10-17
CA2186595A1 (fr) 1995-10-05
EP0811016A1 (fr) 1997-12-10
EP0811016A4 (fr) 1997-12-10
WO1995026365A1 (fr) 1995-10-05
CN1146772A (zh) 1997-04-02

Similar Documents

Publication Publication Date Title
JPH09510975A (ja) アレルギー治療用合成ペプチドベース免疫原
JP4031201B2 (ja) アレルギー治療用免疫原としてのペプチド組成物
US6713301B1 (en) Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
US5759551A (en) Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
TW200533681A (en) Immunogenic peptide carrier conjugates and methods of producing same
WO1996012740A1 (fr) Immunogenes peptidiques synthetiques du domaine d'ancrage de la membrane de l'ige
US20090105150A1 (en) Angiotensin derivatives
CS131891A3 (en) Vaccine
AU2005282231B2 (en) Truncated LHRH formulations
US7378489B1 (en) Angiotensin derivatives
US20090105155A1 (en) Truncated lhrh formulations
Wang B cell & T cell epitope orientation and adjuvant-free immunization in synthetic vaccine design
MXPA00011938A (en) Peptide composition as immunogen for the treatment of allergy
HK1036804B (en) Peptide composition as immunogen for the treatment of allergy
HK1143950B (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens
HK1037860B (en) Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens